UMMY20033 /Steroid Sparing Treatment/ Frank Passero
Basic Study Information
Purpose:
The purpose of this study is to determine the effects of daratumumab and lenalidomide
without steroids for treating patients with multiple myeloma.
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Frank Passero
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search